AU2001255378A1 - Inhibition of transmission of tick-borne infections - Google Patents

Inhibition of transmission of tick-borne infections

Info

Publication number
AU2001255378A1
AU2001255378A1 AU2001255378A AU5537801A AU2001255378A1 AU 2001255378 A1 AU2001255378 A1 AU 2001255378A1 AU 2001255378 A AU2001255378 A AU 2001255378A AU 5537801 A AU5537801 A AU 5537801A AU 2001255378 A1 AU2001255378 A1 AU 2001255378A1
Authority
AU
Australia
Prior art keywords
tick
inhibition
transmission
borne infections
borne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255378A
Other languages
English (en)
Inventor
Alan B. Barbour
Deborah C. Jaworski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001255378A1 publication Critical patent/AU2001255378A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43552—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects
    • G01N2333/43556—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from insects from ticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU2001255378A 2000-04-14 2001-04-13 Inhibition of transmission of tick-borne infections Abandoned AU2001255378A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19711300P 2000-04-14 2000-04-14
US60197113 2000-04-14
PCT/US2001/012189 WO2001078770A1 (fr) 2000-04-14 2001-04-13 Inhibition de la transmission d'infections vehiculees par les tiques

Publications (1)

Publication Number Publication Date
AU2001255378A1 true AU2001255378A1 (en) 2001-10-30

Family

ID=22728093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255378A Abandoned AU2001255378A1 (en) 2000-04-14 2001-04-13 Inhibition of transmission of tick-borne infections

Country Status (2)

Country Link
AU (1) AU2001255378A1 (fr)
WO (1) WO2001078770A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005024022A1 (fr) * 2003-09-10 2005-03-17 The Governors Of The University Of Alberta Proteines de facteur d'engorgement de tiques
ES2329584T3 (es) * 2003-12-24 2009-11-27 Merck Serono Sa Proteinas de garrapatas de union a quimiocinas cc.
WO2015144732A2 (fr) * 2014-03-25 2015-10-01 Yale University Utilisations de facteurs inhibiteurs de la migration de macrophages de parasite

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681724A (en) * 1995-11-16 1997-10-28 Heska Corporation Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
WO2001078770A1 (fr) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2001240978A1 (en) Glycogen phosphorylase inhibitor
AU2002356333A1 (en) Bore isolation
AU2001266068A1 (en) Treatment of mineral substrates
AU2002363710A1 (en) Ball-worm transmission
AU2001234088A1 (en) TNF-alpha inhibitors
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2002304853A1 (en) Substituted benzopyranones as telomerase inhibitors
AU2001267604A1 (en) Estimation of movement
AU2001232245A1 (en) Tnf- alpha inhibitors
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
AU2002301492A1 (en) Transmission
AU2002214883A1 (en) Isolation of taxanes
AU2001255378A1 (en) Inhibition of transmission of tick-borne infections
AU4673801A (en) Transmission of data
AU2002352376A1 (en) Isolation of microwave transmission lines
AU2001258675A1 (en) Treating infections
AU2002305868A1 (en) Inhibitors of reggamma
AU2001272490A1 (en) Use of galiella lactone
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2001286584A1 (en) Inhibition of protein-protein interaction
AU2001231983A1 (en) Delayed release of fluids
AU2335601A (en) Treatment or prevention of diarrhea
AU2002216038A1 (en) Preparation of monofluoroalkenes
AU7246701A (en) Novel telomerase inhibitors